Abstract:To find new substitution of islet β cells for treating diabetes,rat bone marrow mesenchymal stem cells (BMSCs) were isolated,cultured,identified and induced into islet β cells in vitro.Isolation of rat BMSCs by the whole bone marrow centrifugation and adherence method,then BMSCs were cultured,subcultured,detected cell surface markers and induced into islet β cells by DMSO and high glucose environment.The results showed that the morphology of BMSCs was fibroblast like,with active passage ability.CD 13,CD44 and CD 106 antigens were detected,but CD49d antigen was negative.Under the condition of islet β cells induction,BMSCs could form isletlike round cell mass,dithizone staining was brownish red,PDX1,CK19,nestin and insulin antigens were positive using immunohistochemistry staining.BMSCs induction into islet β cells expressed insulin,PDX1 and glucagon detected by RT-PCR.The expression quantity of insulin mRNA in differentiated BMSCs was 1.09 times (P＞0.05) than that of in pancreas adult stem cells (PASCs) detected by q-PCR.At the same time,differentiated BMSCs had the corresponding expression of insulin protein.The results demonstrated that rat BMSCs grow stably in vitro,and can be converted into islet-like cells,providing new experimental basis for diabetes treatment.

Cultivation, Identification and Islet β Cells Induction of Bone Marrow Mesenchymal Stem Cells in Rats